Capital Research Global Investors lifted its stake in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 22.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,469,752 shares of the company’s stock after purchasing an additional 268,192 shares during the quarter. Capital Research Global Investors owned about 0.08% of Addus HomeCare worth $157,837,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. 8 Knots Management LLC acquired a new stake in Addus HomeCare during the third quarter worth $6,075,000. Adage Capital Partners GP L.L.C. acquired a new stake in Addus HomeCare during the second quarter worth $4,838,000. Vanguard Group Inc. increased its stake in Addus HomeCare by 2.9% during the third quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock worth $153,163,000 after acquiring an additional 36,674 shares during the last quarter. Punch & Associates Investment Management Inc. increased its stake in Addus HomeCare by 29.1% during the third quarter. Punch & Associates Investment Management Inc. now owns 143,655 shares of the company’s stock worth $16,950,000 after acquiring an additional 32,355 shares during the last quarter. Finally, Raymond James Financial Inc. increased its stake in Addus HomeCare by 5,969.5% during the third quarter. Raymond James Financial Inc. now owns 32,047 shares of the company’s stock worth $3,781,000 after acquiring an additional 31,519 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Trading Down 1.5%
Shares of NASDAQ ADUS opened at $90.71 on Tuesday. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The stock has a fifty day simple moving average of $93.83 and a 200-day simple moving average of $103.76. The stock has a market capitalization of $1.69 billion, a PE ratio of 16.77, a PEG ratio of 1.26 and a beta of 0.89.
Analyst Ratings Changes
Several research firms have issued reports on ADUS. Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Citizens Jmp reissued a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.22.
View Our Latest Stock Report on ADUS
Addus HomeCare Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Stories
- Five stocks we like better than Addus HomeCare
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
